AI Insight
Stanford Medicine researchers have identified a naturally occurring molecule called BRP that suppresses appetite and reduces body weight similarly to Ozempic, but with a more targeted mechanism of action. Unlike Ozempic, which affects tissues throughout the body, BRP acts specifically on brain regions involved in hunger and metabolism, potentially avoiding common side effects associated with current weight-loss medications. This discovery could lead to new therapeutic approaches for obesity treatment with improved tolerability.
Why it matters
This finding could enable development of weight-loss treatments that maintain efficacy while reducing gastrointestinal and other side effects that cause many patients to discontinue current medications like Ozempic. The more targeted brain-based mechanism may offer a safer long-term option for obesity management.
Understand the Science
Stanford Medicine researchers have discovered a naturally occurring molecule that may suppress appetite and reduce body weight much like Ozempic, but without several of its common side effects. The molecule, called BRP, acts on a more targeted region of the brain involved in hunger and metabolism rather than affecting tissues throughout the body.
Source: AI helps Stanford scientists discover “natural Ozempic” without the usual side effects